COMMUNIQUÉS West-GlobeNewswire

CareDx’s AlloSeq cfDNA and QTYPE Solutions Featured at EFI 2019
07/05/2019
CareDx leadership in transplant innovation highlighted through multiple podium and poster presentations BRISBANE, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics [...]
CohBar Appoints Steven B. Engle as Chief Executive Officer
07/05/2019
MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy [...]
Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update
07/05/2019
SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various [...]
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
07/05/2019
Conference Call Scheduled for Tuesday, May 14, 2019 at 9:00 AM ET PORTLAND, Maine, May 07, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company [...]
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual Meeting
07/05/2019
Ublituximab treatment continues to be well tolerated with a median duration of follow-up of 97.5 weeks NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company [...]
Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and Patient-Clinician Conversations in Parkinson’s Disease
07/05/2019
Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON and MELBOURNE, [...]
Driven Deliveries Inc. to Present at The MoneyShow in Las Vegas On May 13th 2019
07/05/2019
Management will also participate in Panel Discussion. Investing in Cannabis SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first publicly traded cannabis delivery company, [...]
CV Sciences, Inc. to Present at Upcoming Investor Conferences
07/05/2019
LAS VEGAS, May 07, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating [...]
Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union
07/05/2019
WAYLIVRA is the only therapy for Familial Chylomicronemia Syndrome, or FCS, a devastating, ultra-rare disease BOSTON and CARLSBAD, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an [...]
OLAH Healthcare Technology Welcomes Chad Hill as Vice President of Operations
07/05/2019
COLUMBUS, Ohio, May 07, 2019 (GLOBE NEWSWIRE) -- On April 15, Chad Hill joined OLAH Healthcare Technology as Vice President of Operations, assuming responsibility for operational management of OLAH’s client services [...]
Better Choice Company Announces Closing of TruPet and Bona Vida Acquisitions
07/05/2019
The closing positions the Company with first-mover advantage within the pet CBD industry BROOKLYN, N.Y., May 07, 2019 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (OTCQB: BTTR) (the “Company”) today announced the [...]
Acer Therapeutics to Present at UBS Global Healthcare Conference
07/05/2019
NEWTON, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Caladrius Biosciences to Participate at the Upcoming May Conferences
07/05/2019
BASKING RIDGE, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]
Maple Leaf Announces Non-Brokered Private Placement for Corporate Development and General Working Capital Purposes
07/05/2019
CALGARY, Alberta, May 07, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) is pleased to announce that it intends to complete a non-brokered private [...]
Trinity Biotech Announces Results for Q1, 2019
07/05/2019
DUBLIN, Ireland, May 07, 2019 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]
ACACIA PHARMA: NOTICE OF ANNUAL GENERAL MEETING
07/05/2019
ACACIA PHARMA: NOTICE OF ANNUAL GENERAL MEETING Cambridge, UK and Indianapolis, US – 7 May 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on [...]
ExCellThera enters into a manufacturing and collaboration agreement with New York Blood Center
07/05/2019
MONTREAL, May 07, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, [...]
INmune Bio Closes Private Placement of Approximately $4.1 Million of Common Stock, Led by Insiders and Existing Shareholders
07/05/2019
LA JOLLA, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14
07/05/2019
Management to host conference call and webcast at 8am ET TEL AVIV, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the [...]

Pages